SENP1: A perspective from immune cells to disease (Review)
Authors:
Open Access
- 15 July 2025
- journal article
- review article
- Published by Spandidos Publications in Oncology Reports
- Vol. 54 (3) , 1-15
Abstract
Small ubiquitin‑like modifier (SUMO) is a ubiquitin‑like protein that modifies target proteins across various eukaryotic subcellular structures. This process, known as SUMOylation, has been established as an essential regulatory mechanism that affects both the activity and positioning of proteins, maintaining cellular homeostasis. SUMOylation and deSUMOylation are reversible post‑translational modification processes mediated by SUMO proteins and SUMO/sentrin‑specific proteases (SENPs). The human SENP family comprises six members, each characterized by unique cellular localization and substrate specificity. The present review primarily summarizes the role and mechanisms of SENP1 in the development and maturation of immune cells, including lymphocytes, macrophages and erythrocytes, as well as its involvement in tumor cell invasion, metastasis, angiogenesis and resistance to pharmacological therapies. In addition, the introduction of SENP1 inhibitors as a therapeutic approach for cancer treatment is explored. Overall, the present study aimed to offer theoretical insights into cancer therapy strategies that target SENP1.Keywords
This publication has 183 references indexed in Scilit:
- Orphan Nuclear Receptor Nur77 Is Involved in Caspase-independent Macrophage Cell DeathJournal of Experimental Medicine, 2003
- Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptorsNature, 2003
- ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitroBlood, 2003
- TGF- β signaling in cancer – a double-edged swordTrends in Cell Biology, 2001
- Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing EnzymeCell, 2000
- Differential Regulation of Sentrinized Proteins by a Novel Sentrin-specific ProteaseJournal of Biological Chemistry, 2000
- IκB–NF-κB StructuresCell, 1998
- Repression of c- myc Transcription by Blimp-1, an Inducer of Terminal B Cell DifferentiationScience, 1997
- A Small Ubiquitin-Related Polypeptide Involved in Targeting RanGAP1 to Nuclear Pore Complex Protein RanBP2Cell, 1997
- Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cellsCell, 1994